Huaren Pharmaceutical Co., Ltd. (300110.SZ)
CNY 2.9
(3.2%)
CNY 2.9
(3.2%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 334.62 Million CNY | 25.4% |
| 2022 | 266.84 Million CNY | -3.13% |
| 2021 | 275.47 Million CNY | 6.38% |
| 2020 | 258.96 Million CNY | 34.03% |
| 2019 | 193.2 Million CNY | -0.94% |
| 2018 | 195.05 Million CNY | -1.69% |
| 2017 | 198.39 Million CNY | 6.17% |
| 2016 | 186.86 Million CNY | -12.04% |
| 2015 | 212.45 Million CNY | 14.68% |
| 2014 | 185.24 Million CNY | 56.96% |
| 2013 | 118.02 Million CNY | 34.33% |
| 2012 | 87.86 Million CNY | 83.91% |
| 2011 | 47.77 Million CNY | -4.89% |
| 2010 | 50.23 Million CNY | 3.91% |
| 2009 | 48.34 Million CNY | 78.68% |
| 2008 | 27.05 Million CNY | 10.45% |
| 2007 | 24.49 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 310.68 Million CNY | -2.63% |
| 2024 Q1 | 319.19 Million CNY | -4.61% |
| 2024 Q2 | 319.06 Million CNY | -0.04% |
| 2023 Q1 | 243.71 Million CNY | -8.67% |
| 2023 FY | 334.62 Million CNY | 25.4% |
| 2023 Q2 | 297.68 Million CNY | 22.14% |
| 2023 Q3 | 342.31 Million CNY | 15.0% |
| 2023 Q4 | 334.62 Million CNY | -2.25% |
| 2022 Q2 | 272.67 Million CNY | 6.81% |
| 2022 Q4 | 266.84 Million CNY | -10.67% |
| 2022 FY | 266.84 Million CNY | -3.13% |
| 2022 Q3 | 298.71 Million CNY | 9.55% |
| 2022 Q1 | 255.3 Million CNY | -7.32% |
| 2021 Q3 | 301.49 Million CNY | 3.15% |
| 2021 Q1 | 287.67 Million CNY | 11.09% |
| 2021 Q2 | 292.29 Million CNY | 1.6% |
| 2021 Q4 | 275.47 Million CNY | -8.63% |
| 2021 FY | 275.47 Million CNY | 6.38% |
| 2020 FY | 258.96 Million CNY | 34.03% |
| 2020 Q3 | 200.31 Million CNY | -9.86% |
| 2020 Q2 | 222.22 Million CNY | 5.68% |
| 2020 Q4 | 258.96 Million CNY | 29.28% |
| 2020 Q1 | 210.28 Million CNY | 8.84% |
| 2019 FY | 193.2 Million CNY | -0.94% |
| 2019 Q3 | 175.73 Million CNY | -9.29% |
| 2019 Q4 | 193.2 Million CNY | 9.94% |
| 2019 Q1 | 200.05 Million CNY | 2.56% |
| 2019 Q2 | 193.74 Million CNY | -3.15% |
| 2018 Q4 | 195.05 Million CNY | -2.85% |
| 2018 FY | 195.05 Million CNY | -1.69% |
| 2018 Q1 | 199.74 Million CNY | 0.68% |
| 2018 Q2 | 200.59 Million CNY | 0.43% |
| 2018 Q3 | 200.78 Million CNY | 0.09% |
| 2017 Q4 | 198.39 Million CNY | 6.99% |
| 2017 FY | 198.39 Million CNY | 6.17% |
| 2017 Q3 | 185.42 Million CNY | 2.85% |
| 2017 Q2 | 180.29 Million CNY | -10.58% |
| 2017 Q1 | 201.63 Million CNY | 7.9% |
| 2016 FY | 186.86 Million CNY | -12.04% |
| 2016 Q4 | 186.86 Million CNY | -1.44% |
| 2016 Q3 | 189.59 Million CNY | -9.16% |
| 2016 Q2 | 208.7 Million CNY | -1.36% |
| 2016 Q1 | 211.59 Million CNY | -0.4% |
| 2015 FY | 212.45 Million CNY | 14.68% |
| 2015 Q1 | 214.24 Million CNY | 15.66% |
| 2015 Q2 | 218.2 Million CNY | 1.84% |
| 2015 Q3 | 223.21 Million CNY | 2.3% |
| 2015 Q4 | 212.45 Million CNY | -4.82% |
| 2014 Q1 | 139.13 Million CNY | 17.88% |
| 2014 FY | 185.24 Million CNY | 56.96% |
| 2014 Q3 | 156.02 Million CNY | 5.5% |
| 2014 Q2 | 147.88 Million CNY | 6.29% |
| 2014 Q4 | 185.24 Million CNY | 18.73% |
| 2013 Q3 | 142.04 Million CNY | 9.4% |
| 2013 Q4 | 118.02 Million CNY | -16.91% |
| 2013 FY | 118.02 Million CNY | 34.33% |
| 2013 Q1 | 129.02 Million CNY | 46.84% |
| 2013 Q2 | 129.83 Million CNY | 0.63% |
| 2012 Q1 | 54.95 Million CNY | 15.02% |
| 2012 Q4 | 87.86 Million CNY | -15.57% |
| 2012 FY | 87.86 Million CNY | 83.91% |
| 2012 Q3 | 104.06 Million CNY | 106.65% |
| 2012 Q2 | 50.35 Million CNY | -8.36% |
| 2011 Q1 | 52.3 Million CNY | 4.13% |
| 2011 FY | 47.77 Million CNY | -4.89% |
| 2011 Q3 | 53.14 Million CNY | -10.46% |
| 2011 Q2 | 59.35 Million CNY | 13.47% |
| 2011 Q4 | 47.77 Million CNY | -10.1% |
| 2010 Q2 | 52.33 Million CNY | 0.0% |
| 2010 Q4 | 50.23 Million CNY | -8.25% |
| 2010 Q3 | 54.74 Million CNY | 4.61% |
| 2010 FY | 50.23 Million CNY | 3.91% |
| 2009 Q4 | 48.34 Million CNY | 0.0% |
| 2009 FY | 48.34 Million CNY | 78.68% |
| 2008 FY | 27.05 Million CNY | 10.45% |
| 2007 FY | 24.49 Million CNY | 0.0% |